Barts Revascularisation Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorQueen Mary University of London
About this trial
Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide.
This data will add to that literature by assessing the characteristics and outcomes of patients with CAD. It will also identify and characterise predictors of outcomes, improve risk stratification and diagnostic evaluation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes.
No children will be included in this study.
Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team.
Both male and female patients ≥16 years of age will be included
Disqualifiers
None
Trial population
This study will include all patients admitted to or reviewed at Barts Heart Centre (St. Bartholomew's Hospital) who undergo revascularisation. These patients range from young adults to the elderly and will include any patient ≥16 years of age. Patients who are followed up with and without any intervention (i.e. both medically managed patients as well as patients undergoing intervention) are equally as important and therefore we shall include both groups of patients. Patients will be included from referrals made by other clinicians either as in or outpatients. All these patients have their clinical data captured on a database or hospital based clinical programme.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Observation only
Other interventionObservation only
Treatment groups
20,000 Participants
are divided into 1 treatment groupGroup A: Patients undergoing Revascularisation at Barts Heart Centre1 intervention
Trial outcomes
Primary outcomes
1
Mortality
Assessment of Mortality
Time frame
1 year2
Re-admission rates post Revascularisation
Re-admission
Time frame
1 year3
MACE post Revascularisation
MACE
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov